PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate

By: via Benzinga
PharmaCyte Biotech Inc(NASDAQ: PMCB)updated its activities to lift the FDA's clinical holdon PharmaCyte's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.